Sodium Butyrate Reduces Brain Amyloid-β Levels and Improves Cognitive Memory Performance in an Alzheimer’s Disease Transgenic Mouse Model at an Early Disease Stage-Reference-Cited by-同舟云学术

Sodium Butyrate Reduces Brain Amyloid-β Levels and Improves Cognitive Memory Performance in an Alzheimer’s Disease Transgenic Mouse Model at an Early Disease Stage

Published:2020-03-10 Issue:1 Volume:74 Page:91-99
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Fernando W.M.A.D. Binosha¹²,Martins Ian J.¹²³,Morici Michael¹,Bharadwaj Prashant¹²⁴,Rainey-Smith Stephanie R.¹²,Lim Wei Ling Florence¹³,Martins Ralph N.¹²³⁵

Affiliation:

1. Centre of Excellence for Alzheimer’s Disease Research and Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia

2. Australian Alzheimer’s Research Foundation, Ralph and Patricia Sarich Neuroscience Research Institute, Nedlands, WA, Australia

3. Co-operative Research Centre (CRC) for Mental Health, Australia

4. School of Pharmacy and Biomedical Sciences, Faculty of Health Sciences, Curtin University, Bentley, WA, Australia

5. School of Biomedical Sciences, Macquarie University, NSW, Australia

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference51 articles.

1. Neuropathology of Alzheimer’s disease;Perl;J Mt Sinai Hosp N Y,2010

2. Stability of the preclinical episodic memory deficit in Alzheimer’s disease;Backman;Brain,2001

3. The aging brain and cognition: Contribution of vascular injury and abeta to mild cognitive dysfunction;Marchant;JAMA Neurol,2013